Motley Fool43d agoneutral
Here's Where Wall Street Analysts See Eli Lilly's Share Price GoingNews
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
109last 24h
3129last 7d
511● bullish (7d)
313● bearish (7d)
227publishers
Motley Fool43d agoneutral
Lilly Cut an Obesity Drug -- but the Move Shows How High Its Bar Has BecomeInsider Monkey44d agoneutral
Eli Lilly (LLY) vs. Novo Nordisk (NVO): Has the GLP-1 Race Changed the Moat?Simply Wall St.44d agobullish
Eli Lilly (LLY) Wins Two FDA Approvals And A $3.35 Billion Drug AllianceStocktwits44d agoneutral
Biotech Deal Week: Lilly, Novo And Novartis Pay Up For Platforms, Not PipelinesMT Newswires44d agobullish
Update: Nektar Wins $90 Million Jury Verdict Against Eli Lilly Over Rezpegaldesleukin DealBioPharma Dive44d agobearish
Novo pursues long-acting obesity drugs; Acadia slumps on Alzheimer’s dataMotley Fool44d agobullish
Viking Therapeutics Soared After Its Latest GLP-1 Data. Is It Too Late to Buy?Motley Fool45d agobullish
AbbVie vs. Eli Lilly: Which Star Pharma Stock Is a Better Buy in 2026?Pharmaceutical Technology45d agoneutral
Eli Lilly outlays $3.35bn for secretive drug discovery pact with China’s InnoCare